Torben Ek

1.4k total citations · 1 hit paper
30 papers, 938 citations indexed

About

Torben Ek is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Torben Ek has authored 30 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Torben Ek's work include Childhood Cancer Survivors' Quality of Life (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and DNA Repair Mechanisms (4 papers). Torben Ek is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (6 papers), Acute Lymphoblastic Leukemia research (6 papers) and DNA Repair Mechanisms (4 papers). Torben Ek collaborates with scholars based in Sweden, Denmark and United States. Torben Ek's co-authors include Jonas Abrahamsson, Ulrike Resch, Anetta Härtlová, Nelson O. Gekara, Saskia F. Erttmann, Lotta Mellander, Jonas A. Nilsson, Lisa M. Nilsson, Stefan Lienenklaus and Andrea Kröger and has published in prestigious journals such as SHILAP Revista de lepidopterología, Immunity and Scientific Reports.

In The Last Decade

Torben Ek

27 papers receiving 925 citations

Hit Papers

DNA Damage Primes the Type I Interferon System via the Cy... 2015 2026 2018 2022 2015 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torben Ek Sweden 13 478 406 232 146 116 30 938
Lauren Young United States 11 511 1.1× 323 0.8× 241 1.0× 76 0.5× 253 2.2× 24 1.1k
Suzanne Skoda‐Smith United States 13 579 1.2× 394 1.0× 137 0.6× 167 1.1× 172 1.5× 26 1.0k
Kjetil Hestdal Norway 18 813 1.7× 261 0.6× 197 0.8× 231 1.6× 181 1.6× 30 1.3k
Fabien Touzot France 21 458 1.0× 490 1.2× 175 0.8× 161 1.1× 192 1.7× 45 1.2k
Sean Agbor-Enoh United States 17 224 0.5× 326 0.8× 204 0.9× 81 0.6× 33 0.3× 80 1.2k
Myew–Ling Toh France 18 541 1.1× 213 0.5× 185 0.8× 120 0.8× 174 1.5× 23 1.0k
Kevin Goudy United States 19 564 1.2× 377 0.9× 166 0.7× 100 0.7× 68 0.6× 22 1.3k
Kozo Nagai Japan 17 238 0.5× 253 0.6× 232 1.0× 99 0.7× 179 1.5× 50 1000
Gholamreza Bahari Iran 19 241 0.5× 620 1.5× 155 0.7× 140 1.0× 38 0.3× 93 1.1k
Atar Lev Israel 19 729 1.5× 230 0.6× 78 0.3× 184 1.3× 112 1.0× 78 1.1k

Countries citing papers authored by Torben Ek

Since Specialization
Citations

This map shows the geographic impact of Torben Ek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torben Ek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torben Ek more than expected).

Fields of papers citing papers by Torben Ek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torben Ek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torben Ek. The network helps show where Torben Ek may publish in the future.

Co-authorship network of co-authors of Torben Ek

This figure shows the co-authorship network connecting the top 25 collaborators of Torben Ek. A scholar is included among the top collaborators of Torben Ek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torben Ek. Torben Ek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Delgado-Vega, A M, Fulya Taylan, Kristina Lagerstedt‐Robinson, et al.. (2024). Occurrence of cancer in Marfan syndrome: Report of two patients with neuroblastoma and review of the literature. American Journal of Medical Genetics Part A. 194(12). e63812–e63812.
2.
Djos, Anna, Johanna Svensson, Ganesh Umapathy, et al.. (2024). Loss of Chromosome Y in Neuroblastoma Is Associated With High‐Risk Disease, 11q‐Deletion, and Telomere Maintenance. Genes Chromosomes and Cancer. 63(7). e23260–e23260. 2 indexed citations
3.
Vogt, Hartmut, Anders Castor, Josefine Palle, et al.. (2024). Effects of allopurinol on 6-mercaptopurine metabolism in unselected patients with pediatric acute lymphoblastic leukemia: a prospective phase II study. Haematologica. 109(9). 2846–2853. 2 indexed citations
4.
Arvidson, Johan, et al.. (2023). Pain in pediatric oncology—A Swedish nationwide follow‐up study among nurses and physicians. SHILAP Revista de lepidopterología. 6(2). 27–34.
5.
Djos, Anna, Roshan Vaid, Ganesh Umapathy, et al.. (2023). Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX Genes. Cancers. 15(24). 5732–5732. 3 indexed citations
6.
Sandeberg, Margareta af, Maria Olsson, Torben Ek, et al.. (2023). Nurses’ Perceptions of the Impact of a National Educational Program in Pediatric Oncology Nursing: A Cross-Sectional Evaluation. PubMed. 40(3). 178–187. 2 indexed citations
7.
Hammarsten, Ola, Torben Ek, Anders Fasth, et al.. (2022). Clinical measurement of cellular DNA damage hypersensitivity in patients with DNA repair defects. Orphanet Journal of Rare Diseases. 17(1). 50–50. 1 indexed citations
8.
Ludvigsson, Johnny, Sri Ramulu Elluru, Per Leanderson, et al.. (2020). Combined Vitamin D, Ibuprofen and Glutamic Acid decarboxylase-alum Treatment in Recent Onset Type I Diabetes: Lessons from the DIABGAD Randomized Pilot Trial. Future Science OA. 6(7). FSO604–FSO604. 9 indexed citations
9.
Fransson, Susanne, Rose‐Marie Sjöberg, Gustaf Ljungman, et al.. (2020). Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance. Scientific Reports. 10(1). 22432–22432. 19 indexed citations
10.
Erttmann, Saskia F., Anetta Härtlová, Marta Słoniecka, et al.. (2016). Loss of the DNA Damage Repair Kinase ATM Impairs Inflammasome-Dependent Anti-Bacterial Innate Immunity. Immunity. 45(1). 106–118. 37 indexed citations
11.
Johansson, Pegah, et al.. (2016). A flow cytometry assay that measures cellular sensitivity to DNA-damaging agents, customized for clinical routine laboratories. Clinical Biochemistry. 49(7-8). 566–572. 6 indexed citations
12.
Härtlová, Anetta, Saskia F. Erttmann, Ulrike Resch, et al.. (2015). DNA Damage Primes the Type I Interferon System via the Cytosolic DNA Sensor STING to Promote Anti-Microbial Innate Immunity. Immunity. 42(2). 332–343. 537 indexed citations breakdown →
13.
Russo, Roberta, Maria Rosaria Esposito, Antonella Gambale, et al.. (2013). Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II. Blood Cells Molecules and Diseases. 51(1). 17–21. 29 indexed citations
14.
Knobe, Karin, et al.. (2012). Lupus anticoagulants in two children—bleeding due to nonphospholipid-dependent antiprothrombin antibodies. European Journal of Pediatrics. 171(9). 1383–1387. 19 indexed citations
15.
Ek, Torben, Mats Josefson, & Jonas Abrahamsson. (2011). Multivariate analysis of the relation between immune dysfunction and treatment intensity in children with acute lymphoblastic leukemia. Pediatric Blood & Cancer. 56(7). 1078–1087. 12 indexed citations
16.
Ljungman, Gustaf, Åke Jakobson, Mikael Behrendtz, et al.. (2010). Incidence and survival analyses in children with solid tumours diagnosed in Sweden between 1983 and 2007. Acta Paediatrica. 100(5). 750–757. 12 indexed citations
17.
Ek, Torben, Lotta Mellander, Mirjana Hahn‐Zoric, & Jonas Abrahamsson. (2006). Avidity of Tetanus and Hib antibodies after childhood acute lymphoblastic leukaemia – implications for vaccination strategies. Acta Paediatrica. 95(6). 701–706. 15 indexed citations
18.
Ek, Torben, et al.. (2005). Ara-C Fever and Infections After High-Dose Ara-C Treatment in Pediatric Lymphoid Malignancies. Journal of Pediatric Hematology/Oncology. 27(7). 364–369. 12 indexed citations
19.
Ek, Torben, Lotta Mellander, & Jonas Abrahamsson. (2005). Interferon γ and tumour necrosis factor α in relation to anaemia and prognosis in childhood cancer. Acta Paediatrica. 94(4). 435–437. 5 indexed citations
20.
Ek, Torben, Lotta Mellander, Bengt Åndersson, & Jonas Abrahamsson. (2004). Immune reconstitution after childhood acute lymphoblastic leukemia is most severely affected in the high risk group. Pediatric Blood & Cancer. 44(5). 461–468. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026